Amphastar Pharmaceuticals, Inc.
AMPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $152 | $144 | $156 | $126 |
| Short-Term Investments | $70 | $113 | $20 | $10 |
| Receivables | $138 | $115 | $89 | $79 |
| Inventory | $154 | $106 | $104 | $93 |
| Other Curr. Assets | $21 | $11 | $10 | $10 |
| Total Curr. Assets | $534 | $490 | $378 | $318 |
| Property Plant & Equip (Net) | $345 | $316 | $265 | $271 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $588 | $610 | $34 | $36 |
| Long-Term Investments | $11 | $15 | $2 | $4 |
| Tax Assets | $71 | $53 | $39 | $22 |
| Other NC Assets | $26 | $26 | $21 | $17 |
| Total NC Assets | $1,043 | $1,023 | $364 | $353 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,577 | $1,513 | $742 | $672 |
| Liabilities | – | – | – | – |
| Payables | $31 | $25 | $21 | $22 |
| Short-Term Debt | $7 | $4 | $6 | $5 |
| Tax Payable | $10 | $2 | $5 | $9 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $127 | $194 | $64 | $67 |
| Total Curr. Liab. | $174 | $225 | $95 | $104 |
| LT Debt | $644 | $619 | $97 | $99 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $7 | $6 | $7 | $7 |
| Other NC Liab. | $21 | $23 | $15 | $16 |
| Total NC Liab. | $671 | $648 | $118 | $122 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $49 | $34 | $27 | $28 |
| Total Liabilities | $845 | $873 | $213 | $226 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $569 | $409 | $272 | $180 |
| AOCI | -$9 | -$8 | -$9 | -$7 |
| Other Equity | $173 | $239 | $266 | $272 |
| Total Equity | $732 | $639 | $529 | $446 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,577 | $1,513 | $742 | $672 |
| Net Debt | $499 | $479 | -$54 | -$22 |